Epigenomics, Volume 16, Issue 9 (2024)

Browse this journal

Epigenomics, Volume 16, Issue 9 (2024)

See all volumes and issues
Volume 16, 2024 Vol 15, 2023 Vol 14, 2022 Vol 13, 2021 Vol 12, 2020 Vol 11, 2019 Vol 10, 2018 Vol 9, 2017 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 4, 2012 Vol 3, 2011 Vol 2, 2010 Vol 1, 2009
Download citations Download PDFs Download issue

Epigenomics

Articles

Article
Coregulatory effects of multiple histone modifications in key ferroptosis-related genes for lung adenocarcinoma
Ye-Chen Qi, Hui Bai, Si-Le Hu, Shu-Juan Li & Qian-Zhong Li
Pages: 609-633
Published online: 21 Mar 2024
AbstractforCoregulatory effects of multiple histone modifications in key ferroptosis-related genes for lung adenocarcinoma | Full Text | References | PDF (5.5 MB) | EPUB | Supplemental
  • 57 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Toward a more holistic approach to the study of exposures and child outcomes
Barry M Lester, Marie Camerota, Todd M Everson, Coral L Shuster & Carmen J Marsit
Pages: 635-651
Published online: 14 Mar 2024
AbstractforToward a more holistic approach to the study of exposures and child outcomes | Full Text | References | PDF (3.8 MB) | EPUB | Supplemental
  • 446 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response
Irene Fischetti, Laura Botti, Roberta Sulsenti, Valeria Cancila, Claudia Enriquez, Renata Ferri, Marco Bregni, Filippo Crivelli, Claudio Tripodo, Mario P. Colombo & Elena Jachetti
Pages: 653-670
Published online: 26 Mar 2024
AbstractforCombined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response | Full Text | References | PDF (36.5 MB) | EPUB | Supplemental
  • 935 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Report
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics
Nazanin Zohourian & James AL Brown
Pages: 671-680
Published online: 19 Apr 2024
AbstractforCurrent trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics | Full Text | References | PDF (2.5 MB) | EPUB
  • 32 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Super-enhancers: drivers of cells’ identities and cells’ debacles
Mélanie Lavaud, Robel Tesfaye, Léa Lassous, Bénédicte Brounais, Marc Baud'huin, Franck Verrecchia, François Lamoureux, Steven Georges & Benjamin Ory
Pages: 681-700
Published online: 08 Apr 2024
AbstractforSuper-enhancers: drivers of cells’ identities and cells’ debacles | Full Text | References | PDF (6 MB) | EPUB | Supplemental
  • 71 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High methylation of the same promoter of lncRNA ZNF582-AS1/ZNF582 promotes malignant progression of esophageal cancer
Zhupeng Li et al.
Article | Published online: 4 Jun 2024
Novel epigenetic roles of lactylation in osteogenesis
Kiyohito Sasa et al.
Editorial | Published online: 3 Jun 2024
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors
Min Kyung Lee et al.
Rapid Communication | Published online: 21 May 2024
Open Access
Cell-free DNA methylation patterns in aging and their association with inflamm-aging
Si-Jia Li et al.
Article | Published online: 15 May 2024
View all latest articles